Verily and Kyverna Therapeutics Announce Collaboration to Advance Cell Therapy for Autoimmune Diseases

Kyverna will utilize Verily’s Immune Profiler to advance biomarker discovery and longitudinal data collection strategies to drive efficient, enhanced clinical trials SOUTH SAN FRANCISCO, Calif. and EMERYVILLE, Calif., Sept. 7, 2023 /PRNewswire/ — Verily, an Alphabet precision health…

Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks